Literature DB >> 19092638

Deep vein thrombosis prophylaxis: friend or foe.

Siamak Rahman1.   

Abstract

This article reviews certain aspects of venous thromboembolism, a major cause of morbidity and mortality among hospitalized patients. Deep vein thrombosis is a frequent complication of various surgical procedures. Knowing predisposing factors, including hereditary causes, and triggering risk factors will help us identify patients with high risk of venous thromboembolism. The prophylaxis recommendations by American College of Chest Physicians are made for groups of patients, for whom the benefits seem to outweigh the risks. However, those readers who want to adopt the American College of Chest Physicians' guidelines in their practices are urged to review in detail the pharmacology of the drugs used for thromboprophylaxis, relevant clinical studies, and case reports of spinal hematoma. Each patient might have different risks for thrombosis or bleeding and the potential for adverse consequences due to the prophylaxis. What is best for the group (the epidemiologic perspective) is not necessarily what is best for the individual patient (the clinical perspective).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19092638     DOI: 10.1097/MJT.0b013e318183d549

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  3 in total

1.  Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.

Authors:  Yang Zhou; Sudipta Chakraborty; Shuang Liu
Journal:  Theranostics       Date:  2011-01-18       Impact factor: 11.556

2.  Assessing the age of deep vein thrombus: A need for future perioperative medicine and anesthesia.

Authors:  Anurag Aggarwal; Anju R Bhalotra; Varun Suresh; Abdul Raheem Al-Qattan
Journal:  Anesth Essays Res       Date:  2016 Jan-Apr

Review 3.  Efficacy and Safety of Enoxaparin versus New Oral Anticoagulants to Prevent Venous Thromboembolism after Total Hip Replacement: A Systematic Review and Meta-Analysis.

Authors:  Mohammed Farhan A Alfarhan
Journal:  J Pers Med       Date:  2022-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.